Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 24;9:433–442. doi: 10.2147/CEOR.S135065

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Gerace et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Distribution based on age classes and disease severity stages.

Notes: (A and B) Patient distribution based on age classes. The majority of the population is represented by subjects over 60 years old (74%), while younger patients are fewer (22% for subjects 45–60 years old and 4% for subjects under 45 years old). (C and D) Patient distribution based on disease severity stages. The most significant percentage of urothelial bladder cancer patients (62%) is in the superficial disease stage, muscle-invasive percentage is 14% for cisplatinum-fit patients and 12% for cisplatinum-unfit patients. Metastatic disease represents the terminal stage and appears in 12% of subjects.